Analysis plan and sample size calculations
On the basis of PROCAS-1 results we anticipated that ~12% of women using BC-Predict in PROCAS-2 would have sufficient risk to be considered for BCPM and that approximately 10% of these would take it up [Two-sided chi square tests were used to assess differences in uptake between BC-Predict and standard NHSBSP controls using Fisher’s exact test (